Introduction of 7‐day amotosalen/ultraviolet A light pathogen‐reduced platelets in Honduras: Impact on platelet availability in a lower middle‐income country

Documenti analoghi

• The safety of pathogen‐reduced platelet transfusions in critically ill term and preterm neonates
  di: Alexia D'hont, et al.
  Pubblicazione: (2024)
• Meta‐analysis of efficacy and safety of pathogen‐reduced platelet components: Request for clarification
  di: Nancy M. Heddle, et al.
  Pubblicazione: (2024)
• Therapeutic efficacy and safety of pathogen‐reduced platelet components: Results of a meta‐analysis of randomized controlled trials
  di: Joan Cid, et al.
  Pubblicazione: (2024)
• A tight interplay between platelet activation and mitochondrial DNA release promotes platelet storage lesion in platelet concentrates
  di: Kamand Haeri, et al.
  Pubblicazione: (2024)
• Optimized pathogen reduction of double‐dose platelets pooled from seven buffy coats using the TACSI® system
  di: Alice Lorusso, et al.
  Pubblicazione: (2025)